Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Sana Biotechnology (SANA) PT Raised to $15 at Citi, Opens Positive Catalyst Watch
August 9, 2024 5:01 AM EDTCiti analyst Samantha Semenkow raised the price target on Sana Biotechnology (NASDAQ: SANA) to $15.00 (from $8.00) while maintaining a Buy rating.
The analyst comments "Sana disclosed they have enrolled multiple T1D patients into the IST being conducted in Uppsala, Sweden. The... More
